Global Human Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Global Human Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
1.1 Human Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Varicella
1.2.3 Influenza
1.2.4 Polio
1.2.5 Hepatitis A
1.2.6 Rabies
1.2.7 BCG
1.2.8 Hepatitis B
1.2.9 Pertussis, Diphtheria, Tetanus
1.2.10 Pneumococcal
1.2.11 Rota vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Adults
1.3.3 Children
1.4 Global Human Vaccine Market Size & Forecast
1.4.1 Global Human Vaccine Sales in Value (2016-2026))
1.4.2 Global Human Vaccine Sales in Volume (2016-2026)
1.4.3 Global Human Vaccine Price by Type (2016-2026) & (USD/Dose)
1.5 Global Human Vaccine Production Capacity Analysis
1.5.1 Global Human Vaccine Total Production Capacity (2016-2026)
1.5.2 Global Human Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Vaccine Market Drivers
1.6.2 Human Vaccine Market Restraints
1.6.3 Human Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 CNBG
2.1.1 CNBG Details
2.1.2 CNBG Major Business
2.1.3 CNBG Human Vaccine Product and Services
2.1.4 CNBG Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Changsheng Life
2.2.1 Changsheng Life Details
2.2.2 Changsheng Life Major Business
2.2.3 Changsheng Life Human Vaccine Product and Services
2.2.4 Changsheng Life Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Zhifei
2.3.1 Zhifei Details
2.3.2 Zhifei Major Business
2.3.3 Zhifei Human Vaccine Product and Services
2.3.4 Zhifei Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 ChengDa Bio
2.4.1 ChengDa Bio Details
2.4.2 ChengDa Bio Major Business
2.4.3 ChengDa Bio Human Vaccine Product and Services
2.4.4 ChengDa Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Kangtai
2.5.1 Kangtai Details
2.5.2 Kangtai Major Business
2.5.3 Kangtai Human Vaccine Product and Services
2.5.4 Kangtai Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 SINOVAC BIOTECH
2.6.1 SINOVAC BIOTECH Details
2.6.2 SINOVAC BIOTECH Major Business
2.6.3 SINOVAC BIOTECH Human Vaccine Product and Services
2.6.4 SINOVAC BIOTECH Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Hissen
2.7.1 Hissen Details
2.7.2 Hissen Major Business
2.7.3 Hissen Human Vaccine Product and Services
2.7.4 Hissen Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Walvax Biotechnology
2.8.1 Walvax Biotechnology Details
2.8.2 Walvax Biotechnology Major Business
2.8.3 Walvax Biotechnology Human Vaccine Product and Services
2.8.4 Walvax Biotechnology Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 GSK
2.9.1 GSK Details
2.9.2 GSK Major Business
2.9.3 GSK Human Vaccine Product and Services
2.9.4 GSK Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 SANOFI
2.10.1 SANOFI Details
2.10.2 SANOFI Major Business
2.10.3 SANOFI Human Vaccine Product and Services
2.10.4 SANOFI Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Rong An
2.11.1 Rong An Details
2.11.2 Rong An Major Business
2.11.3 Rong An Human Vaccine Product and Services
2.11.4 Rong An Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 NuoCheng Bio
2.12.1 NuoCheng Bio Details
2.12.2 NuoCheng Bio Major Business
2.12.3 NuoCheng Bio Human Vaccine Product and Services
2.12.4 NuoCheng Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Hualan Bio
2.13.1 Hualan Bio Details
2.13.2 Hualan Bio Major Business
2.13.3 Hualan Bio Human Vaccine Product and Services
2.13.4 Hualan Bio Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Tiantan biological
2.14.1 Tiantan biological Details
2.14.2 Tiantan biological Major Business
2.14.3 Tiantan biological Human Vaccine Product and Services
2.14.4 Tiantan biological Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Changchun Baike
2.15.1 Changchun Baike Details
2.15.2 Changchun Baike Major Business
2.15.3 Changchun Baike Human Vaccine Product and Services
2.15.4 Changchun Baike Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Adimmune
2.16.1 Adimmune Details
2.16.2 Adimmune Major Business
2.16.3 Adimmune Human Vaccine Product and Services
2.16.4 Adimmune Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Zhongyianke Biotech
2.17.1 Zhongyianke Biotech Details
2.17.2 Zhongyianke Biotech Major Business
2.17.3 Zhongyianke Biotech Human Vaccine Product and Services
2.17.4 Zhongyianke Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Bharat Biotech
2.18.1 Bharat Biotech Details
2.18.2 Bharat Biotech Major Business
2.18.3 Bharat Biotech Human Vaccine Product and Services
2.18.4 Bharat Biotech Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Bavarian Nordic
2.19.1 Bavarian Nordic Details
2.19.2 Bavarian Nordic Major Business
2.19.3 Bavarian Nordic Human Vaccine Product and Services
2.19.4 Bavarian Nordic Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Sanofi-Pasteur
2.20.1 Sanofi-Pasteur Details
2.20.2 Sanofi-Pasteur Major Business
2.20.3 Sanofi-Pasteur Human Vaccine Product and Services
2.20.4 Sanofi-Pasteur Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Indian Immunologicals
2.21.1 Indian Immunologicals Details
2.21.2 Indian Immunologicals Major Business
2.21.3 Indian Immunologicals Human Vaccine Product and Services
2.21.4 Indian Immunologicals Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 KANGH
2.22.1 KANGH Details
2.22.2 KANGH Major Business
2.22.3 KANGH Human Vaccine Product and Services
2.22.4 KANGH Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Henan Grand Biopharma
2.23.1 Henan Grand Biopharma Details
2.23.2 Henan Grand Biopharma Major Business
2.23.3 Henan Grand Biopharma Human Vaccine Product and Services
2.23.4 Henan Grand Biopharma Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 ZhongKe Biopharm
2.24.1 ZhongKe Biopharm Details
2.24.2 ZhongKe Biopharm Major Business
2.24.3 ZhongKe Biopharm Human Vaccine Product and Services
2.24.4 ZhongKe Biopharm Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 Zhuoyi Biological
2.25.1 Zhuoyi Biological Details
2.25.2 Zhuoyi Biological Major Business
2.25.3 Zhuoyi Biological Human Vaccine Product and Services
2.25.4 Zhuoyi Biological Human Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Human Vaccine Sales by Manufacturer
3.1 Global Human Vaccine Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Human Vaccine Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Human Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Human Vaccine Manufacturer Market Share
3.4.2 Top 6 Human Vaccine Manufacturer Market Share
3.5 Global Human Vaccine Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Human Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Vaccine Market Size by Region
4.1.1 Global Human Vaccine Sales in Volume by Region (2016-2026)
4.1.2 Global Human Vaccine Revenue by Region (2016-2026)
4.2 North America Human Vaccine Revenue (2016-2026)
4.3 Europe Human Vaccine Revenue (2016-2026)
4.4 Asia-Pacific Human Vaccine Revenue (2016-2026)
4.5 South America Human Vaccine Revenue (2016-2026)
4.6 Middle East and Africa Human Vaccine Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Human Vaccine Sales in Volume by Type (2016-2026)
5.2 Global Human Vaccine Revenue by Type (2016-2026)
5.3 Global Human Vaccine Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Human Vaccine Sales in Volume by Application (2016-2026)
6.2 Global Human Vaccine Revenue by Application (2016-2026)
6.3 Global Human Vaccine Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Human Vaccine Sales by Type (2016-2026)
7.2 North America Human Vaccine Sales by Application (2016-2026)
7.3 North America Human Vaccine Market Size by Country
7.3.1 North America Human Vaccine Sales in Volume by Country (2016-2026)
7.3.2 North America Human Vaccine Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Vaccine Sales by Type (2016-2026)
8.2 Europe Human Vaccine Sales by Application (2016-2026)
8.3 Europe Human Vaccine Market Size by Country
8.3.1 Europe Human Vaccine Sales in Volume by Country (2016-2026)
8.3.2 Europe Human Vaccine Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Human Vaccine Sales by Type (2016-2026)
9.2 Asia-Pacific Human Vaccine Sales by Application (2016-2026)
9.3 Asia-Pacific Human Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Vaccine Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Human Vaccine Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Human Vaccine Sales by Type (2016-2026)
10.2 South America Human Vaccine Sales by Application (2016-2026)
10.3 South America Human Vaccine Market Size by Country
10.3.1 South America Human Vaccine Sales in Volume by Country (2016-2026)
10.3.2 South America Human Vaccine Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Vaccine Sales by Type (2016-2026)
11.2 Middle East & Africa Human Vaccine Sales by Application (2016-2026)
11.3 Middle East & Africa Human Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Vaccine Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Human Vaccine Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Human Vaccine Typical Distributors
12.3 Human Vaccine Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Human Vaccine Revenue by Type, (USD Million), 2021-2026
Table 2. Global Human Vaccine Revenue by Application, (USD Million), 2021-2026
Table 3. CNBG Basic Information, Manufacturing Base and Competitors
Table 4. CNBG Major Business
Table 5. CNBG Human Vaccine Product and Services
Table 6. CNBG Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Changsheng Life Basic Information, Manufacturing Base and Competitors
Table 8. Changsheng Life Major Business
Table 9. Changsheng Life Human Vaccine Product and Services
Table 10. Changsheng Life Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Zhifei Basic Information, Manufacturing Base and Competitors
Table 12. Zhifei Major Business
Table 13. Zhifei Human Vaccine Product and Services
Table 14. Zhifei Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. ChengDa Bio Basic Information, Manufacturing Base and Competitors
Table 16. ChengDa Bio Major Business
Table 17. ChengDa Bio Human Vaccine Product and Services
Table 18. ChengDa Bio Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Kangtai Basic Information, Manufacturing Base and Competitors
Table 20. Kangtai Major Business
Table 21. Kangtai Human Vaccine Product and Services
Table 22. Kangtai Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. SINOVAC BIOTECH Basic Information, Manufacturing Base and Competitors
Table 24. SINOVAC BIOTECH Major Business
Table 25. SINOVAC BIOTECH Human Vaccine Product and Services
Table 26. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Hissen Basic Information, Manufacturing Base and Competitors
Table 28. Hissen Major Business
Table 29. Hissen Human Vaccine Product and Services
Table 30. Hissen Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Walvax Biotechnology Basic Information, Manufacturing Base and Competitors
Table 32. Walvax Biotechnology Major Business
Table 33. Walvax Biotechnology Human Vaccine Product and Services
Table 34. Walvax Biotechnology Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. GSK Basic Information, Manufacturing Base and Competitors
Table 36. GSK Major Business
Table 37. GSK Human Vaccine Product and Services
Table 38. GSK Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. SANOFI Basic Information, Manufacturing Base and Competitors
Table 40. SANOFI Major Business
Table 41. SANOFI Human Vaccine Product and Services
Table 42. SANOFI Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Rong An Basic Information, Manufacturing Base and Competitors
Table 44. Rong An Major Business
Table 45. Rong An Human Vaccine Product and Services
Table 46. Rong An Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. NuoCheng Bio Basic Information, Manufacturing Base and Competitors
Table 48. NuoCheng Bio Major Business
Table 49. NuoCheng Bio Human Vaccine Product and Services
Table 50. NuoCheng Bio Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 52. Hualan Bio Major Business
Table 53. Hualan Bio Human Vaccine Product and Services
Table 54. Hualan Bio Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Tiantan biological Basic Information, Manufacturing Base and Competitors
Table 56. Tiantan biological Major Business
Table 57. Tiantan biological Human Vaccine Product and Services
Table 58. Tiantan biological Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Changchun Baike Basic Information, Manufacturing Base and Competitors
Table 60. Changchun Baike Major Business
Table 61. Changchun Baike Human Vaccine Product and Services
Table 62. Changchun Baike Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Adimmune Basic Information, Manufacturing Base and Competitors
Table 64. Adimmune Major Business
Table 65. Adimmune Human Vaccine Product and Services
Table 66. Adimmune Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Zhongyianke Biotech Basic Information, Manufacturing Base and Competitors
Table 68. Zhongyianke Biotech Major Business
Table 69. Zhongyianke Biotech Human Vaccine Product and Services
Table 70. Zhongyianke Biotech Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 72. Bharat Biotech Major Business
Table 73. Bharat Biotech Human Vaccine Product and Services
Table 74. Bharat Biotech Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 76. Bavarian Nordic Major Business
Table 77. Bavarian Nordic Human Vaccine Product and Services
Table 78. Bavarian Nordic Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 80. Sanofi-Pasteur Major Business
Table 81. Sanofi-Pasteur Human Vaccine Product and Services
Table 82. Sanofi-Pasteur Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Indian Immunologicals Basic Information, Manufacturing Base and Competitors
Table 84. Indian Immunologicals Major Business
Table 85. Indian Immunologicals Human Vaccine Product and Services
Table 86. Indian Immunologicals Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. KANGH Basic Information, Manufacturing Base and Competitors
Table 88. KANGH Major Business
Table 89. KANGH Human Vaccine Product and Services
Table 90. KANGH Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Henan Grand Biopharma Basic Information, Manufacturing Base and Competitors
Table 92. Henan Grand Biopharma Major Business
Table 93. Henan Grand Biopharma Human Vaccine Product and Services
Table 94. Henan Grand Biopharma Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. ZhongKe Biopharm Basic Information, Manufacturing Base and Competitors
Table 96. ZhongKe Biopharm Major Business
Table 97. ZhongKe Biopharm Human Vaccine Product and Services
Table 98. ZhongKe Biopharm Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. Zhuoyi Biological Basic Information, Manufacturing Base and Competitors
Table 100. Zhuoyi Biological Major Business
Table 101. Zhuoyi Biological Human Vaccine Product and Services
Table 102. Zhuoyi Biological Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Global Human Vaccine Sales by Manufacturer (2019-2021e) & (M Doses)
Table 104. Global Human Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 105. Market Position of Manufacturers in Human Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 106. Global Human Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 107. Head Office and Human Vaccine Production Site of Key Manufacturer
Table 108. Human Vaccine New Entrant and Capacity Expansion Plans
Table 109. Human Vaccine Mergers & Acquisitions in the Past Five Years
Table 110. Global Human Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 111. Global Human Vaccine Sales by Region (2021-2026) & (M Doses)
Table 112. Global Human Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 113. Global Human Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 114. Global Human Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 115. Global Human Vaccine Sales by Type (2021-2026) & (M Doses)
Table 116. Global Human Vaccine Revenue by Type (2016-2021e) & (USD Million)
Table 117. Global Human Vaccine Revenue by Type (2021-2026) & (USD Million)
Table 118. Global Human Vaccine Price by Type (2016-2021e) & (USD/Dose)
Table 119. Global Human Vaccine Price by Type (2021-2026) & (USD/Dose)
Table 120. Global Human Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 121. Global Human Vaccine Sales by Application (2021-2026) & (M Doses)
Table 122. Global Human Vaccine Revenue by Application (2016-2021e) & (USD Million)
Table 123. Global Human Vaccine Revenue by Application (2021-2026) & (USD Million)
Table 124. Global Human Vaccine Price by Application (2016-2021e) & (USD/Dose)
Table 125. Global Human Vaccine Price by Application (2021-2026) & (USD/Dose)
Table 126. North America Human Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 127. North America Human Vaccine Sales by Country (2021-2026) & (M Doses)
Table 128. North America Human Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 129. North America Human Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 130. North America Human Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 131. North America Human Vaccine Sales by Type (2021-2026) & (M Doses)
Table 132. North America Human Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 133. North America Human Vaccine Sales by Application (2021-2026) & (M Doses)
Table 134. Europe Human Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 135. Europe Human Vaccine Sales by Country (2021-2026) & (M Doses)
Table 136. Europe Human Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 137. Europe Human Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 138. Europe Human Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 139. Europe Human Vaccine Sales by Type (2021-2026) & (M Doses)
Table 140. Europe Human Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 141. Europe Human Vaccine Sales by Application (2021-2026) & (M Doses)
Table 142. Asia-Pacific Human Vaccine Sales by Region (2016-2021e) & (M Doses)
Table 143. Asia-Pacific Human Vaccine Sales by Region (2021-2026) & (M Doses)
Table 144. Asia-Pacific Human Vaccine Revenue by Region (2016-2021e) & (USD Million)
Table 145. Asia-Pacific Human Vaccine Revenue by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Human Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 147. Asia-Pacific Human Vaccine Sales by Type (2021-2026) & (M Doses)
Table 148. Asia-Pacific Human Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 149. Asia-Pacific Human Vaccine Sales by Application (2021-2026) & (M Doses)
Table 150. South America Human Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 151. South America Human Vaccine Sales by Country (2021-2026) & (M Doses)
Table 152. South America Human Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 153. South America Human Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 154. South America Human Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 155. South America Human Vaccine Sales by Type (2021-2026) & (M Doses)
Table 156. South America Human Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 157. South America Human Vaccine Sales by Application (2021-2026) & (M Doses)
Table 158. Middle East & Africa Human Vaccine Sales by Country (2016-2021e) & (M Doses)
Table 159. Middle East & Africa Human Vaccine Sales by Country (2021-2026) & (M Doses)
Table 160. Middle East & Africa Human Vaccine Revenue by Country (2016-2021e) & (USD Million)
Table 161. Middle East & Africa Human Vaccine Revenue by Country (2021-2026) & (USD Million)
Table 162. Middle East & Africa Human Vaccine Sales by Type (2016-2021e) & (M Doses)
Table 163. Middle East & Africa Human Vaccine Sales by Type (2021-2026) & (M Doses)
Table 164. Middle East & Africa Human Vaccine Sales by Application (2016-2021e) & (M Doses)
Table 165. Middle East & Africa Human Vaccine Sales by Application (2021-2026) & (M Doses)
Table 166. Direct Channel Pros & Cons
Table 167. Indirect Channel Pros & Cons
Table 168. Human Vaccine Typical Distributors
Table 169. Human Vaccine Typical Customers
List of Figures
Figure 1. Human Vaccine Picture
Figure 2. Global Human Vaccine Sales Market Share by Type in 2020
Figure 3. Varicella
Figure 4. Influenza
Figure 5. Polio
Figure 6. Hepatitis A
Figure 7. Rabies
Figure 8. BCG
Figure 9. Hepatitis B
Figure 10. Pertussis, Diphtheria, Tetanus
Figure 11. Pneumococcal
Figure 12. Rota vaccine
Figure 13. Global Human Vaccine Sales Market Share by Application in 2020
Figure 14. Adults
Figure 15. Children
Figure 16. Global Human Vaccine Market Size, (USD Million) & (M Doses): 2020 VS 2021 VS 2026
Figure 17. Global Human Vaccine Market Size and Forecast (2016-2026) & (USD Million)
Figure 18. Global Human Vaccine Sales (2016-2026) & (M Doses)
Figure 19. Global Human Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 20. Global Human Vaccine Production Capacity (2016-2026) & (M Doses)
Figure 21. Global Human Vaccine Production Capacity by Geographic Region: 2020 VS 2021
Figure 22. Human Vaccine Market Drivers
Figure 23. Human Vaccine Market Restraints
Figure 24. Human Vaccine Market Trends
Figure 25. Global Human Vaccine Sales Market Share by Manufacturer in 2020
Figure 26. Global Human Vaccine Revenue Market Share by Manufacturer in 2020
Figure 27. Human Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 28. Top 3 Human Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 29. Top 6 Human Vaccine Manufacturer (Revenue) Market Share in 2020
Figure 30. Global Human Vaccine Sales Market Share by Region (2016-2026)
Figure 31. Global Human Vaccine Revenue Market Share by Region (2016-2026)
Figure 32. North America Human Vaccine Revenue (2016-2026) & (USD Million)
Figure 33. Europe Human Vaccine Revenue (2016-2026) & (USD Million)
Figure 34. Asia-Pacific Human Vaccine Revenue (2016-2026) & (USD Million)
Figure 35. South America Human Vaccine Revenue (2016-2026) & (USD Million)
Figure 36. Middle East & Africa Human Vaccine Revenue (2016-2026) & (USD Million)
Figure 37. Global Human Vaccine Sales Market Share by Type (2016-2026)
Figure 38. Global Human Vaccine Revenue Market Share by Type (2016-2026)
Figure 39. Global Human Vaccine Price by Type (2016-2026) & (USD/Dose)
Figure 40. Global Human Vaccine Sales Market Share by Application (2016-2026)
Figure 41. Global Human Vaccine Revenue Market Share by Application (2016-2026)
Figure 42. Global Human Vaccine Price by Application (2016-2026) & (USD/Dose)
Figure 43. North America Human Vaccine Sales Market Share by Type (2016-2026)
Figure 44. North America Human Vaccine Sales Market Share by Application (2016-2026)
Figure 45. North America Human Vaccine Sales Market Share by Country (2016-2026)
Figure 46. North America Human Vaccine Revenue Market Share by Country (2016-2026)
Figure 47. United States Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Canada Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Mexico Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Europe Human Vaccine Sales Market Share by Type (2016-2026)
Figure 51. Europe Human Vaccine Sales Market Share by Application (2016-2026)
Figure 52. Europe Human Vaccine Sales Market Share by Country (2016-2026)
Figure 53. Europe Human Vaccine Revenue Market Share by Country (2016-2026)
Figure 54. Germany Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. France Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. United Kingdom Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Russia Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Italy Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Asia-Pacific Human Vaccine Sales Market Share by Region (2016-2026)
Figure 60. Asia-Pacific Human Vaccine Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Human Vaccine Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Human Vaccine Revenue Market Share by Region (2016-2026)
Figure 63. China Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Korea Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Human Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Human Vaccine Sales Market Share by Type (2016-2026)
Figure 70. South America Human Vaccine Sales Market Share by Application (2016-2026)
Figure 71. South America Human Vaccine Sales Market Share by Country (2016-2026)
Figure 72. South America Human Vaccine Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Human Vaccine Revenue and Growth Rate (2016-2026) & (USD M

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs